$APYP
APPYEA, INC

2018 Q2 Form 10-Q Financial Statement

#000164033418001064 Filed on May 21, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2018 Q1 2017 Q1
Revenue -$10.00K $11.80K $178.00
YoY Change 6528.65% -94.99%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $110.0K $130.0K $140.0K
YoY Change -50.0% -7.14% 787.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $6.500K $10.81K
YoY Change -100.0% -39.86% -40.23%
% of Gross Profit
Operating Expenses $140.0K $136.4K $146.5K
YoY Change -39.13% -6.92% 8.98%
Operating Profit -$124.6K -$146.3K
YoY Change -14.87% 11.8%
Interest Expense -$500.0K $112.9K $10.51K
YoY Change 257.14% 975.0% -85.85%
% of Operating Profit
Other Income/Expense, Net -$272.5K -$5.230K
YoY Change 5110.71% -93.14%
Pretax Income -$650.0K -$400.0K -$150.0K
YoY Change 75.68% 166.67% -28.57%
Income Tax
% Of Pretax Income
Net Earnings -$650.0K -$397.1K -$151.6K
YoY Change 75.68% 162.02% -26.82%
Net Earnings / Revenue -3365.45% -85141.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.10 -$0.07 -$0.07
COMMON SHARES
Basic Shares Outstanding 1.200B shares 1.146B shares 469.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00K $0.00 $20.00K
YoY Change 25.0% -100.0%
Cash & Equivalents $47.20K $1.258K $20.60K
Short-Term Investments
Other Short-Term Assets $40.00K
YoY Change -33.33%
Inventory
Prepaid Expenses $36.00K
Receivables $10.00K
Other Receivables $0.00
Total Short-Term Assets $47.20K $12.90K $56.60K
YoY Change 10.87% -77.21% -11.74%
LONG-TERM ASSETS
Property, Plant & Equipment $7.300K $13.80K $49.85K
YoY Change -81.3% -72.32% -47.05%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $24.52K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.300K $38.32K $49.85K
YoY Change -81.3% -23.12% -47.05%
TOTAL ASSETS
Total Short-Term Assets $47.20K $12.90K $56.60K
Total Long-Term Assets $7.300K $38.32K $49.85K
Total Assets $54.50K $51.22K $106.4K
YoY Change -33.22% -51.88% -32.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $280.0K $200.0K $3.858K
YoY Change 4572.12% 5084.03% 228.34%
Accrued Expenses $2.484K $200.0K $100.0K
YoY Change 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $210.0K $190.0K
YoY Change 76.47% 10.53% 137.5%
Total Short-Term Liabilities $1.904M $1.270M $347.4K
YoY Change 283.25% 265.69% 29.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.904M $1.270M $347.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.904M $1.270M $347.4K
YoY Change 283.25% 265.69% 29.37%
SHAREHOLDERS EQUITY
Retained Earnings -$6.777M -$6.124M -$4.410M
YoY Change 41.7% 38.86% 23.36%
Common Stock $124.0K $116.8K $46.47K
YoY Change 138.57% 151.45% 154.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.850M -$1.219M -$240.9K
YoY Change
Total Liabilities & Shareholders Equity $54.50K $51.22K $106.4K
YoY Change -33.22% -51.88% -32.74%

Cashflow Statement

Concept 2018 Q2 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$650.0K -$397.1K -$151.6K
YoY Change 75.68% 162.02% -26.82%
Depreciation, Depletion And Amortization $0.00 $6.500K $10.81K
YoY Change -100.0% -39.86% -40.23%
Cash From Operating Activities -$10.00K -$10.00K -$100.0K
YoY Change -87.5% -90.0% 900.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K 0.000 110.0K
YoY Change -40.0% -100.0%
NET CHANGE
Cash From Operating Activities -10.00K -10.00K -100.0K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 60.00K 0.000 110.0K
Net Change In Cash 50.00K -10.00K 10.00K
YoY Change 150.0% -200.0% -200.0%
FREE CASH FLOW
Cash From Operating Activities -$10.00K -$10.00K -$100.0K
Capital Expenditures $0.00
Free Cash Flow -$100.0K
YoY Change 900.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
apyp Class Of Warrant Or Right Exercisable Price Per Share
ClassOfWarrantOrRightExercisablePricePerShare
0.0005
dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
dei Entity Central Index Key
EntityCentralIndexKey
0001568969
dei Trading Symbol
TradingSymbol
apyp
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1200477060 shares
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2018-03-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42567 usd
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1258 usd
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14637 usd
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20595 usd
CY2017Q2 us-gaap Assets Current
AssetsCurrent
42567 usd
CY2018Q1 us-gaap Assets Current
AssetsCurrent
12899 usd
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39044 usd
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13800 usd
CY2018Q1 us-gaap Equity Method Investments
EquityMethodInvestments
24524 usd
CY2017Q2 us-gaap Assets
Assets
81611 usd
CY2018Q1 us-gaap Assets
Assets
51223 usd
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5993 usd
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
198071 usd
CY2017Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
128000 usd
CY2018Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
200000 usd
CY2017Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
174904 usd
CY2018Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
200233 usd
CY2017Q2 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
0 usd
CY2018Q1 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
7837 usd
CY2017Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
73608 usd
CY2018Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
87087 usd
CY2017Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
114316 usd
CY2018Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
576984 usd
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
496821 usd
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1270212 usd
CY2017Q2 us-gaap Liabilities
Liabilities
496821 usd
CY2018Q1 us-gaap Liabilities
Liabilities
1270212 usd
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q1 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
51997 usd
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
116841 usd
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4210156 usd
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4725039 usd
CY2017Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
105000 usd
CY2018Q1 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4782863 usd
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6124096 usd
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-415210 usd
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-1218989 usd
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
81611 usd
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51223 usd
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
218826 usd
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
244070 usd
CY2017Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
87240 usd
CY2018Q1 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
57750 usd
CY2017Q2 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q1 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
746 usd
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1500000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
519973313 shares
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1168413424 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
519973313 shares
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1168413424 shares
CY2017Q1 us-gaap Revenues
Revenues
178 usd
us-gaap Revenues
Revenues
719 usd
CY2018Q1 us-gaap Revenues
Revenues
158 usd
us-gaap Revenues
Revenues
1202 usd
CY2017Q1 us-gaap Professional Fees
ProfessionalFees
91308 usd
us-gaap Professional Fees
ProfessionalFees
177811 usd
CY2018Q1 us-gaap Professional Fees
ProfessionalFees
103567 usd
us-gaap Professional Fees
ProfessionalFees
333371 usd
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
44383 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
105640 usd
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26301 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
161397 usd
CY2017Q1 us-gaap Depreciation
Depreciation
10808 usd
us-gaap Depreciation
Depreciation
32792 usd
CY2018Q1 us-gaap Depreciation
Depreciation
6500 usd
us-gaap Depreciation
Depreciation
25244 usd
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
146499 usd
us-gaap Operating Expenses
OperatingExpenses
316243 usd
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
136368 usd
us-gaap Operating Expenses
OperatingExpenses
520012 usd
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-146321 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-315524 usd
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-124569 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-507169 usd
CY2017Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
5276 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
4216 usd
CY2018Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-159104 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-509092 usd
CY2017Q1 us-gaap Interest Expense
InterestExpense
10506 usd
us-gaap Interest Expense
InterestExpense
16495 usd
CY2018Q1 us-gaap Interest Expense
InterestExpense
112940 usd
us-gaap Interest Expense
InterestExpense
324496 usd
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5230 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12279 usd
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-272520 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-834064 usd
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-151551 usd
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1133230709 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
913338132 shares
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
24000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
99500 usd
us-gaap Net Income Loss
NetIncomeLoss
-327803 usd
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-397089 usd
us-gaap Net Income Loss
NetIncomeLoss
-1341233 usd
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
464667527 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
464667527 shares
apyp Issuance Of Convertible Notes For Services
IssuanceOfConvertibleNotesForServices
25000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
9326 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
273744 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
31833 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
11641 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
72000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
72000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7169 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
50752 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-194350 usd
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-129988 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25000 usd
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-25000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
157500 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
91667 usd
apyp Proceeds From Convertible Notes Payable Related Party Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableRelatedPartyNetOfOriginalIssueDiscounts
8333 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
59617 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20050 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
16809 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6571 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
200308 usd
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
113679 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5958 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-41309 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
156331 usd
us-gaap Notes Reduction
NotesReduction
281424 usd
apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
11500 usd
apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
235000 usd
us-gaap Nature Of Operations
NatureOfOperations
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>1. NATURE OF OPERATIONS</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company incorporated a wholly-owned subsidiary, "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On June 9, 2017, the Company entered into a Management Services Agreement (&#8220;MSA&#8221;) with The Diagnostic Group, LLC, A Delaware limited liability company (&#8220;TDG&#8221;) under the terms of which, the Company shall perform activities related to direct marketing of TDG products and services to healthcare providers. The initial term of the Agreement will be for thirty-six (36) months from the effective date. The MSA shall automatically renew for successive one (1) year terms, unless either Party gives the other Party ninety (90) days&#8217; written notice of termination prior to the effective date of any renewal term, or unless the MSA is terminated earlier in accordance with Section 6 of the MSA. The Company will be paid for providing services to directly recruited customers at the rate of 35% of the Net Collected Revenue collected from non-federally funded payors by third party providers affiliated or contracted with TDG for ancillary services ordered by recruited customers less any lab specific costs related to any referred samples and/or services and less any refunds or chargebacks. The Company will be paid by the 15th of each month for Net Collected Revenue from the previous month.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</p>
us-gaap Use Of Estimates
UseOfEstimates
<div> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Use of Estimates</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <div align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px 0px 0px 0in; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.</div> </div>
CY2017Q2 apyp Percentage Net Collected Revenue Paid To Recruited Customers
PercentageNetCollectedRevenuePaidToRecruitedCustomers
0.35 pure
CY2018Q1 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
1257313 usd
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2017Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
250877 usd
CY2018Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
234470 usd
CY2017Q2 us-gaap Interest Payable Current
InterestPayableCurrent
11267 usd
CY2018Q1 us-gaap Interest Payable Current
InterestPayableCurrent
23513 usd
CY2017Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
174904 usd
CY2018Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
200233 usd
CY2017Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
174904 usd
CY2018Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
200233 usd
CY2017Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2017Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5000000 shares
CY2018Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
198181818 shares
apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
42500000 shares
apyp Class Of Warrant Or Right With Reset Feature
ClassOfWarrantOrRightWithResetFeature
150681818 shares
apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2017Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.03
CY2018Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0009
apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0.0005
apyp Class Of Warrant Or Right Weighted Average Exercise Price With Reset Feature
ClassOfWarrantOrRightWeightedAverageExercisePriceWithResetFeature
0.0001
apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0
apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0
apyp Warrants Outstanding Weighted Average Remaining Contractual Life
WarrantsOutstandingWeightedAverageRemainingContractualLife
P2Y2M23D
apyp Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
198181818 shares
CY2018Q1 apyp Class Of Warrant Or Right Weighted Average Exercise Price
ClassOfWarrantOrRightWeightedAverageExercisePrice
0.0009
CY2018Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
19000 usd
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-281424 usd
apyp Number Of Lender
NumberOfLender
2 lender
us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2018Q1 apyp Class Of Warrant Or Right Exercisable Of Common Stock Shares
ClassOfWarrantOrRightExercisableOfCommonStockShares
42500000 shares
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
9326 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
266157 usd
CY2017Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
0 usd
CY2018Q1 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2017Q2 us-gaap Notes Payable
NotesPayable
0 usd
CY2018Q1 us-gaap Notes Payable
NotesPayable
8333 usd
CY2017Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0 usd
CY2018Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
250 usd
CY2017Q2 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
0 usd
CY2018Q1 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
7837 usd
CY2017Q2 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018Q1 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.45 pure
CY2018Q1 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
9371 usd
CY2018Q1 apyp Value Assigned To Derivative Liability Recognized As Debt Discount
ValueAssignedToDerivativeLiabilityRecognizedAsDebtDiscount
8333 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
1038 usd
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0.00 pure
apyp Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
235000 usd
apyp Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
407488 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
101604 usd
CY2017Q4 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
75000000 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000000 shares
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1820 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1863 usd
CY2013Q1 us-gaap Lessor Leasing Arrangements Operating Leases Term Of Contract
LessorLeasingArrangementsOperatingLeasesTermOfContract
P3M
CY2013Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
Three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term.
CY2018Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1500 shares
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 shares of common stock
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
30000000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200 usd
apyp Stock Issued Period For Common Stock Payable
StockIssuedPeriodForCommonStockPayable
57273 usd
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
513440111 shares
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
156330 usd
CY2017Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
55000000 shares
CY2018Q1 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
25000000 shares
CY2017Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
67500 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
17000 usd
CY2018Q1 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
11641 usd
CY2018Q1 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
11641 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
11641 usd
CY2018Q1 us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-476 usd
us-gaap Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee
GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
-476 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-785 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
192078 usd
CY2017Q1 us-gaap Sales Revenue Net
SalesRevenueNet
178 usd
us-gaap Sales Revenue Net
SalesRevenueNet
719 usd
CY2018Q1 us-gaap Sales Revenue Net
SalesRevenueNet
11799 usd
us-gaap Sales Revenue Net
SalesRevenueNet
12843 usd
CY2017Q2 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
105000 usd
CY2018Q1 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
47727 usd

Files In Submission

Name View Source Status
0001640334-18-001064-index-headers.html Edgar Link pending
0001640334-18-001064-index.html Edgar Link pending
0001640334-18-001064.txt Edgar Link pending
0001640334-18-001064-xbrl.zip Edgar Link pending
apyp-20180331.xsd Edgar Link pending
apyp_10q.htm Edgar Link pending
apyp_ex311.htm Edgar Link pending
apyp_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20180331_def.xml Edgar Link unprocessable
apyp-20180331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20180331_lab.xml Edgar Link unprocessable
apyp-20180331.xml Edgar Link completed
apyp-20180331_cal.xml Edgar Link unprocessable